4-Hydroxybutyric Acid
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Gamma Hydroxybutyric Acid.
Abiraterone
The serum concentration of Fluphenazine can be increased when it is combined with Abiraterone.
Acebutolol
Fluphenazine may increase the hypotensive activities of Acebutolol.
Advertisement
Acepromazine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Acepromazine.
Aceprometazine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Aceprometazine.
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Fluphenazine.
Advertisement
Alfaxalone
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Alfaxalone.
Alfentanil
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Alfentanil.
Almotriptan
The risk or severity of adverse effects can be increased when Almotriptan is combined with Fluphenazine.
Advertisement
Aloglutamol
Aloglutamol can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Alphaprodine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Alphaprodine.
Alprazolam
The risk or severity of adverse effects can be increased when Alprazolam is combined with Fluphenazine.
Alprenolol
Fluphenazine may increase the hypotensive activities of Alprenolol.
Aluminum
Aluminium can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Aluminum Hydroxide
Aluminum hydroxide can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
aluminum hydroxide, dried (USP)
Aluminum hydroxide can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Aluminum Magnesium Silicate
Almasilate can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Amantadine
The therapeutic efficacy of Fluphenazine can be decreased when used in combination with Amantadine.
Amiodarone
The metabolism of Fluphenazine can be decreased when combined with Amiodarone.
Amisulpride
Fluphenazine may increase the antipsychotic activities of Amisulpride.
Amitriptyline
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Amitriptyline.
Amobarbital
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Amobarbital.
Amodiaquine
The serum concentration of Fluphenazine can be increased when it is combined with Amodiaquine.
Amoxapine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Amoxapine.
Amphetamine
Fluphenazine may decrease the stimulatory activities of Amphetamine.
Apomorphine
The therapeutic efficacy of Fluphenazine can be decreased when used in combination with Apomorphine.
Aripiprazole
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Aripiprazole.
Artemether
The serum concentration of Fluphenazine can be increased when it is combined with Artemether.
Artesunate
The serum concentration of Fluphenazine can be increased when it is combined with Artesunate.
Articaine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Articaine.
Asenapine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Asenapine.
Atenolol
Fluphenazine may increase the hypotensive activities of Atenolol.
Atomoxetine
The metabolism of Fluphenazine can be decreased when combined with Atomoxetine.
Atovaquone
The serum concentration of Fluphenazine can be increased when it is combined with Atovaquone.
Azelastine
Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Baclofen
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Baclofen.
Barbital
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Barbital.
Benoxinate
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Oxybuprocaine.
Benperidol
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Benperidol.
Benzocaine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Benzocaine.
Benzphetamine
Fluphenazine may decrease the stimulatory activities of Benzphetamine.
Benzyl Alcohol
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Benzyl alcohol.
Betaxolol
The metabolism of Fluphenazine can be decreased when combined with Betaxolol.
Bismuth Subcitrate
Bismuth Subcitrate can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Bismuth Subnitrate
Bismuth subnitrate can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Bisoprolol
Fluphenazine may increase the hypotensive activities of Bisoprolol.
Bopindolol
Fluphenazine may increase the hypotensive activities of Bopindolol.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Fluphenazine.
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Fluphenazine.
Brentuximab Vedotin
The serum concentration of Brentuximab vedotin can be increased when it is combined with Fluphenazine.
Brexpiprazole
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Brexpiprazole.
Brimonidine
Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Fluphenazine.
Bromazepam
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Bromazepam.
Bromocriptine
The therapeutic efficacy of Fluphenazine can be decreased when used in combination with Bromocriptine.
Bromperidol
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Bromperidol.
Brompheniramine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Brompheniramine.
Brotizolam
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Brotizolam.
Bupivacaine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Bupivacaine.
Bupranolol
Fluphenazine may increase the hypotensive activities of Bupranolol.
Buprenorphine
Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Bupropion
The metabolism of Fluphenazine can be decreased when combined with Bupropion.
Buspirone
The risk or severity of adverse effects can be increased when Buspirone is combined with Fluphenazine.
Butabarbital
The risk or severity of adverse effects can be increased when Butabarbital is combined with Fluphenazine.
Butalbital
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Butalbital.
Butamben
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Butamben.
Butobarbital
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Butethal.
Butorphanol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Fluphenazine.
Cabergoline
The risk or severity of adverse effects can be increased when Cabergoline is combined with Fluphenazine.
Calcium Carbonate
Calcium Carbonate can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
CALCIUM CARBONATE, PRECIPITATED
Calcium Carbonate can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Carbamazepine
The risk or severity of adverse effects can be increased when Carbamazepine is combined with Fluphenazine.
Carbinoxamine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Carbinoxamine.
Carisoprodol
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Carisoprodol.
Carteolol
Fluphenazine may increase the hypotensive activities of Carteolol.
Carvedilol
Fluphenazine may increase the hypotensive activities of Carvedilol.
Celecoxib
The metabolism of Fluphenazine can be decreased when combined with Celecoxib.
Celiprolol
Fluphenazine may increase the hypotensive activities of Celiprolol.
Cetirizine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Cetirizine.
Chloral Hydrate
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Chloral hydrate.
Chlordiazepoxide
The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Fluphenazine.
Chlormethiazole
The risk or severity of adverse effects can be increased when Fluphenazine is combined with clomethiazole.
Chlormezanone
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Chlormezanone.
Chloroprocaine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Chloroprocaine.
Chloroquine
The serum concentration of Fluphenazine can be increased when it is combined with Chloroquine.
Chlorpheniramine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Chlorphenamine.
CHLORPHENIRAMINE POLISTIREX
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Chlorphenamine.
Chlorpromazine
The metabolism of Fluphenazine can be decreased when combined with Chlorpromazine.
Chlorprothixene
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Chlorprothixene.
Chlorzoxazone
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Chlorzoxazone.
Cholecalciferol
The metabolism of Fluphenazine can be decreased when combined with Cholecalciferol.
Cimetidine
The metabolism of Fluphenazine can be decreased when combined with Cimetidine.
Cinacalcet
The metabolism of Fluphenazine can be decreased when combined with Cinacalcet.
Citalopram
The metabolism of Fluphenazine can be decreased when combined with Citalopram.
Clemastine
The metabolism of Fluphenazine can be decreased when combined with Clemastine.
Clidinium
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Clidinium.
Clidinium bromide
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Clidinium.
Clobazam
The metabolism of Fluphenazine can be decreased when combined with Clobazam.
Clomipramine
The metabolism of Fluphenazine can be decreased when combined with Clomipramine.
Clonazepam
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Clonazepam.
Clonidine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Clonidine.
Clorazepate
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Clorazepate.
CLORAZEPIC ACID
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Clorazepate.
Clotrimazole
The metabolism of Fluphenazine can be decreased when combined with Clotrimazole.
Clozapine
The metabolism of Fluphenazine can be decreased when combined with Clozapine.
Cobicistat
The serum concentration of Fluphenazine can be increased when it is combined with Cobicistat.
Cocaine
The metabolism of Fluphenazine can be decreased when combined with Cocaine.
Codeine
The risk or severity of adverse effects can be increased when Codeine is combined with Fluphenazine.
Codeine Anhydrous
The risk or severity of adverse effects can be increased when Codeine is combined with Fluphenazine.
CODEINE POLISTIREX
The risk or severity of adverse effects can be increased when Codeine is combined with Fluphenazine.
Colchicine
The serum concentration of Colchicine can be increased when it is combined with Fluphenazine.
Curcumin
The metabolism of Fluphenazine can be decreased when combined with Curcumin.
Cyclizine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Cyclizine.
Cyclobenzaprine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Cyclobenzaprine.
Cyproheptadine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Cyproheptadine.
Dabigatran Etexilate
The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Fluphenazine.
Dantrolene
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Dantrolene.
Dapiprazole
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Dapiprazole.
Dapsone
The serum concentration of Fluphenazine can be increased when it is combined with Dapsone.
Darifenacin
The metabolism of Fluphenazine can be decreased when combined with Darifenacin.
Darunavir
The serum concentration of Fluphenazine can be increased when it is combined with Darunavir.
Delavirdine
The metabolism of Fluphenazine can be decreased when combined with Delavirdine.
Desflurane
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Desflurane.
Desipramine
The metabolism of Fluphenazine can be decreased when combined with Desipramine.
Desloratadine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Desloratadine.
Desvenlafaxine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Desvenlafaxine.
Deutetrabenazine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Deutetrabenazine.
Dexbrompheniramine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Dexbrompheniramine.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Dexmedetomidine.
Dextroamphetamine
Fluphenazine may decrease the stimulatory activities of Dextroamphetamine.
Dextromethorphan
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Fluphenazine.
Dextromoramide
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Dextromoramide.
Dezocine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Dezocine.
Diazepam
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Diazepam.
Dibucaine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Cinchocaine.
Diethylpropion
Fluphenazine may decrease the stimulatory activities of Diethylpropion.
Difenoxin
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Difenoxin.
Dihydrocodeine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Dihydrocodeine.
Dihydroergotamine
The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Fluphenazine.
Dimenhydrinate
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Dimenhydrinate.
Diphenhydramine
The metabolism of Fluphenazine can be decreased when combined with Diphenhydramine.
Diphenoxylate
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Diphenoxylate.
Dothiepin
The metabolism of Fluphenazine can be decreased when combined with Dosulepin.
Doxepin
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Doxepin.
Doxorubicin
The serum concentration of Doxorubicin can be increased when it is combined with Fluphenazine.
Doxorubicin Hydrochloride
The serum concentration of Doxorubicin can be increased when it is combined with Fluphenazine.
Doxycycline
The serum concentration of Fluphenazine can be increased when it is combined with Doxycycline.
Doxycycline Anhydrous
The serum concentration of Fluphenazine can be increased when it is combined with Doxycycline.
Doxylamine
Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Fluphenazine.
Dronedarone
The metabolism of Fluphenazine can be decreased when combined with Dronedarone.
Droperidol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Fluphenazine.
Duloxetine
The metabolism of Fluphenazine can be decreased when combined with Duloxetine.
Dyclonine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Dyclonine.
Edoxaban
The serum concentration of Edoxaban can be increased when it is combined with Fluphenazine.
Efavirenz
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Efavirenz.
Eletriptan
The risk or severity of adverse effects can be increased when Eletriptan is combined with Fluphenazine.
Eliglustat
The metabolism of Fluphenazine can be decreased when combined with Eliglustat.
Enflurane
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Enflurane.
Entacapone
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Entacapone.
ergoloid mesylates, USP
The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Fluphenazine.
Ergonovine
The risk or severity of adverse effects can be increased when Ergonovine is combined with Fluphenazine.
Ergotamine
The risk or severity of adverse effects can be increased when Ergotamine is combined with Fluphenazine.
Escitalopram
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Escitalopram.
Esmolol
Fluphenazine may increase the hypotensive activities of Esmolol.
Estazolam
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Estazolam.
Eszopiclone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Fluphenazine.
Ethanol
Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Ethchlorvynol
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Ethchlorvynol.
Ethosuximide
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Ethosuximide.
Ethotoin
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Ethotoin.
Ethyl Chloride
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Ethyl chloride.
Ethyl Loflazepate
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Ethyl loflazepate.
Ethylmorphine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Ethylmorphine.
Etidocaine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Etidocaine.
Etifoxine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Etifoxine.
Etomidate
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Etomidate.
Everolimus
The serum concentration of Everolimus can be increased when it is combined with Fluphenazine.
Ezogabine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Ezogabine.
Felbamate
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Felbamate.
Fenfluramine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Fenfluramine.
Fentanyl
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Fentanyl.
Fesoterodine
The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Fluphenazine.
Fexofenadine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Fexofenadine.
Flibanserin
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Flibanserin.
Flunarizine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Flunarizine.
Flunitrazepam
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Flunitrazepam.
Fluoxetine
The metabolism of Fluphenazine can be decreased when combined with Fluoxetine.
Flupenthixol
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Flupentixol.
Flurazepam
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Flurazepam.
Fluspirilene
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Fluspirilene.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Fluticasone propionate.
Fluvoxamine
The metabolism of Fluphenazine can be decreased when combined with Fluvoxamine.
Fosphenytoin
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Fosphenytoin.
Fospropofol
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Fospropofol.
Frovatriptan
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Fluphenazine.
Gabapentin
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Gabapentin.
Gabapentin Enacarbil
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Gabapentin Enacarbil.
Glutethimide
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Glutethimide.
Guanfacine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Guanfacine.
Halazepam
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Halazepam.
Halofantrine
The serum concentration of Fluphenazine can be increased when it is combined with Halofantrine.
Haloperidol
The metabolism of Fluphenazine can be decreased when combined with Haloperidol.
Halothane
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Halothane.
Heroin
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Heroin.
Hexobarbital
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Hexobarbital.
Hydrocodone
Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
HYDROCODONE POLISTIREX
Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydromorphone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Fluphenazine.
Hydrotalcite
Hydrotalcite can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Hydroxychloroquine
The serum concentration of Fluphenazine can be increased when it is combined with Hydroxychloroquine.
Hydroxyzine
Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Fluphenazine.
Iloperidone
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Iloperidone.
Imipramine
The metabolism of Fluphenazine can be decreased when combined with Imipramine.
Indinavir
The metabolism of Fluphenazine can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Fluphenazine can be decreased when combined with Indinavir.
Isocarboxazid
The therapeutic efficacy of Fluphenazine can be increased when used in combination with Isocarboxazid.
Isoflurane
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Isoflurane.
Isoniazid
The metabolism of Fluphenazine can be decreased when combined with Isoniazid.
Ketamine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Ketamine.
Ketazolam
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Ketazolam.
Ketoconazole
The metabolism of Fluphenazine can be decreased when combined with Ketoconazole.
Labetalol
Fluphenazine may increase the hypotensive activities of Labetalol.
Lamotrigine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Lamotrigine.
Ledipasvir
The serum concentration of Ledipasvir can be increased when it is combined with Fluphenazine.
Levetiracetam
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Levetiracetam.
Levobetaxolol
Fluphenazine may increase the hypotensive activities of Levobetaxolol.
Levobunolol
Fluphenazine may increase the hypotensive activities of Levobunolol.
Levobupivacaine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Levobupivacaine.
Levocabastine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Levocabastine.
Levocetirizine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Levocetirizine.
Levodopa
The therapeutic efficacy of Fluphenazine can be decreased when used in combination with Levodopa.
Levomethadyl
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Levomethadyl Acetate.
Levomilnacipran
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Levomilnacipran.
Levorphanol
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Levorphanol.
Lidocaine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Lidocaine.
Linezolid
The risk or severity of adverse effects can be increased when Linezolid is combined with Fluphenazine.
Lisdexamfetamine
Fluphenazine may decrease the stimulatory activities of Lisdexamfetamine.
Lisdexamfetamine Dimesylate
Fluphenazine may decrease the stimulatory activities of Lisdexamfetamine.
Lithium
Lithium may increase the neurotoxic activities of Fluphenazine.
Lithium Cation
Lithium may increase the neurotoxic activities of Fluphenazine.
Lofexidine
The therapeutic efficacy of Fluphenazine can be increased when used in combination with Lofexidine.
Lopinavir
The metabolism of Fluphenazine can be decreased when combined with Lopinavir.
Loratadine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Loratadine.
Lorazepam
The risk or severity of adverse effects can be increased when Lorazepam is combined with Fluphenazine.
Lorcaserin
The metabolism of Fluphenazine can be decreased when combined with Lorcaserin.
Lormetazepam
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Lormetazepam.
Loxapine
The risk or severity of adverse effects can be increased when Loxapine is combined with Fluphenazine.
Lumefantrine
The serum concentration of Fluphenazine can be increased when it is combined with Lumefantrine.
Lurasidone
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Lurasidone.
Magaldrate
Magaldrate can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Carbonate
Magnesium carbonate can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Hydroxide
Magnesium hydroxide can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Oxide
Magnesium oxide can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium silicate
Magnesium silicate can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Sulfate
The therapeutic efficacy of Fluphenazine can be increased when used in combination with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The therapeutic efficacy of Fluphenazine can be increased when used in combination with Magnesium sulfate.
Magnesium Trisilicate
Magnesium Trisilicate can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Manidipine
The metabolism of Fluphenazine can be decreased when combined with Manidipine.
Maprotiline
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Maprotiline.
Meclizine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Meclizine.
Mefloquine
The serum concentration of Fluphenazine can be increased when it is combined with Mefloquine.
Melatonin
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Melatonin.
Meperidine
The risk or severity of adverse effects can be increased when Pethidine is combined with Fluphenazine.
Mephentermine
Fluphenazine may decrease the stimulatory activities of Mephentermine.
Mephobarbital
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Methylphenobarbital.
Mepindolol
Fluphenazine may increase the hypotensive activities of Mepindolol.
Mepivacaine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Mepivacaine.
Meprobamate
The risk or severity of adverse effects can be increased when Meprobamate is combined with Fluphenazine.
Mequitazine
Fluphenazine may increase the arrhythmogenic activities of Mequitazine.
Mesoridazine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Mesoridazine.
Metaxalone
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Metaxalone.
Methadone
The metabolism of Fluphenazine can be decreased when combined with Methadone.
Methadyl Acetate
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Methadyl Acetate.
Methamphetamine
Fluphenazine may decrease the stimulatory activities of Methamphetamine.
Methapyrilene
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Methapyrilene.
Methaqualone
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Methaqualone.
Methocarbamol
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Methocarbamol.
Methohexital
The risk or severity of adverse effects can be increased when Methohexital is combined with Fluphenazine.
Methotrimeprazine
Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Methoxyflurane
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Methoxyflurane.
Methsuximide
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Methsuximide.
Methylphenidate
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Methylphenidate.
Metipranolol
Fluphenazine may increase the hypotensive activities of Metipranolol.
Metoclopramide
The risk or severity of adverse effects can be increased when Metoclopramide is combined with Fluphenazine.
Metoprolol
The serum concentration of Metoprolol can be increased when it is combined with Fluphenazine.
Metylperon
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Melperone.
Metyrosine
Fluphenazine may increase the sedative activities of Metyrosine.
Midazolam
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Midazolam.
Midostaurin
The metabolism of Fluphenazine can be decreased when combined with Midostaurin.
Milnacipran
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Milnacipran.
Minocycline
Minocycline may increase the central nervous system depressant (CNS depressant) activities of Fluphenazine.
Mirabegron
The metabolism of Fluphenazine can be decreased when combined with Mirabegron.
Mirtazapine
Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Moclobemide
The risk or severity of adverse effects can be increased when Moclobemide is combined with Fluphenazine.
Molindone
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Molindone.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Fluphenazine.
Nabilone
Nabilone may increase the central nervous system depressant (CNS depressant) activities of Fluphenazine.
Nadolol
Fluphenazine may increase the hypotensive activities of Nadolol.
Nalbuphine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Nalbuphine.
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Fluphenazine.
Naratriptan
The risk or severity of adverse effects can be increased when Naratriptan is combined with Fluphenazine.
Nebivolol
Fluphenazine may increase the hypotensive activities of Nebivolol.
Nefazodone
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Nefazodone.
Nevirapine
The metabolism of Fluphenazine can be decreased when combined with Nevirapine.
Nicardipine
The metabolism of Fluphenazine can be decreased when combined with Nicardipine.
Nilotinib
The metabolism of Fluphenazine can be decreased when combined with Nilotinib.
Nitrazepam
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Nitrazepam.
Nitrous Oxide
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Nitrous oxide.
Nordazepam
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Nordazepam.
Norflurane
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Norflurane.
Normethadone
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Normethadone.
Nortriptyline
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Nortriptyline.
Olanzapine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Olanzapine.
Olopatadine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Olopatadine.
Ondansetron
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Ondansetron.
Opium
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Opium.
Orphenadrine
Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Oxazepam
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Oxazepam.
Oxprenolol
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Oxprenolol.
Oxycodone
The risk or severity of adverse effects can be increased when Oxycodone is combined with Fluphenazine.
Oxymorphone
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Oxymorphone.
p-Hydroxyamphetamine
Fluphenazine may decrease the stimulatory activities of Hydroxyamphetamine.
Paliperidone
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Paliperidone.
Panobinostat
The serum concentration of Fluphenazine can be increased when it is combined with Panobinostat.
Paraldehyde
Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Fluphenazine.
Paroxetine
The metabolism of Fluphenazine can be decreased when combined with Paroxetine.
Pazopanib
The serum concentration of Pazopanib can be increased when it is combined with Fluphenazine.
Peginterferon Alfa-2b
The serum concentration of Fluphenazine can be decreased when it is combined with Peginterferon alfa-2b.
Penbutolol
Fluphenazine may increase the hypotensive activities of Penbutolol.
Pentazocine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Pentazocine.
Pentobarbital
The risk or severity of adverse effects can be increased when Pentobarbital is combined with Fluphenazine.
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Fluphenazine.
Perazine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Perazine.
Perphenazine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Perphenazine.
Phenelzine
The risk or severity of adverse effects can be increased when Phenelzine is combined with Fluphenazine.
Phenobarbital
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Phenobarbital.
Phenoxyethanol
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Phenoxyethanol.
Phentermine
Fluphenazine may decrease the stimulatory activities of Phentermine.
PHENTERMINE RESIN
Fluphenazine may decrease the stimulatory activities of Phentermine.
Phenytoin
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Phenytoin.
Pimozide
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Pimozide.
Pindolol
Fluphenazine may increase the hypotensive activities of Pindolol.
Pipamperone
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Pipamperone.
Pipothiazine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Pipotiazine.
Piribedil
The therapeutic efficacy of Fluphenazine can be decreased when used in combination with Piribedil.
Pirinitramide
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Piritramide.
Pizotyline
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Pizotifen.
Pomalidomide
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Pomalidomide.
Practolol
Fluphenazine may increase the hypotensive activities of Practolol.
Pramipexole
Fluphenazine may increase the sedative activities of Pramipexole.
Pramoxine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Pramocaine.
Prazepam
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Prazepam.
Pregabalin
The therapeutic efficacy of Fluphenazine can be increased when used in combination with Pregabalin.
Prilocaine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Prilocaine.
Primaquine
The serum concentration of Fluphenazine can be increased when it is combined with Primaquine.
Primidone
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Primidone.
Procaine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Procaine.
Procarbazine
The risk or severity of adverse effects can be increased when Procarbazine is combined with Fluphenazine.
Prochlorperazine
The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Fluphenazine.
Proguanil
The serum concentration of Fluphenazine can be increased when it is combined with Proguanil.
Promazine
The metabolism of Fluphenazine can be decreased when combined with Promazine.
Promethazine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Promethazine.
Propafenone
Fluphenazine may increase the hypotensive activities of Propafenone.
Proparacaine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Proparacaine.
Propofol
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Propofol.
Propoxyphene
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Dextropropoxyphene.
Propranolol
Fluphenazine may increase the hypotensive activities of Propranolol.
Protriptyline
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Protriptyline.
Pseudoephedrine
Fluphenazine may decrease the stimulatory activities of Pseudoephedrine.
Pyrimethamine
The serum concentration of Fluphenazine can be increased when it is combined with Pyrimethamine.
Quazepam
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Quazepam.
Quetiapine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Quetiapine.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Quetiapine.
Quinacrine
The serum concentration of Fluphenazine can be increased when it is combined with Quinacrine.
Quinagolide
The therapeutic efficacy of Quinagolide can be decreased when used in combination with Fluphenazine.
Quinidine
The metabolism of Fluphenazine can be decreased when combined with Quinidine.
Quinine
The serum concentration of Fluphenazine can be increased when it is combined with Quinine.
Ramelteon
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Ramelteon.
Ranolazine
The serum concentration of Ranolazine can be increased when it is combined with Fluphenazine.
Rasagiline
The risk or severity of adverse effects can be increased when Rasagiline is combined with Fluphenazine.
Remifentanil
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Remifentanil.
Remoxipride
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Remoxipride.
Reserpine
The risk or severity of adverse effects can be increased when Reserpine is combined with Fluphenazine.
Rifaximin
The serum concentration of Rifaximin can be increased when it is combined with Fluphenazine.
Risperidone
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Risperidone.
Ritonavir
The metabolism of Fluphenazine can be decreased when combined with Ritonavir.
Rizatriptan
The risk or severity of adverse effects can be increased when Rizatriptan is combined with Fluphenazine.
Rolapitant
The metabolism of Fluphenazine can be decreased when combined with Rolapitant.
Ropinirole
Fluphenazine may increase the sedative activities of Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Ropivacaine.
Rotigotine
Fluphenazine may increase the sedative activities of Rotigotine.
Rucaparib
The metabolism of Fluphenazine can be decreased when combined with Rucaparib.
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Fluphenazine.
Scopolamine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Scopolamine.
Scopolamine Hydrobromide
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Scopolamine.
Secobarbital
The risk or severity of adverse effects can be increased when Secobarbital is combined with Fluphenazine.
Selegiline
The risk or severity of adverse effects can be increased when Selegiline is combined with Fluphenazine.
Sertindole
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Sertindole.
Sertraline
The metabolism of Fluphenazine can be decreased when combined with Sertraline.
Sevoflurane
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Sevoflurane.
Silodosin
The serum concentration of Silodosin can be increased when it is combined with Fluphenazine.
Sodium Bicarbonate
Sodium bicarbonate can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sodium Oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Fluphenazine.
Sotalol
Fluphenazine may increase the hypotensive activities of Sotalol.
Sufentanil
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Sufentanil.
Sulfadoxine
The serum concentration of Fluphenazine can be increased when it is combined with Sulfadoxine.
Sulfalene
The serum concentration of Fluphenazine can be increased when it is combined with Sulfametopyrazine.
Sulpiride
Fluphenazine may increase the antipsychotic activities of Sulpiride.
Sumatriptan
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Fluphenazine.
Sumatriptan Succinate
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Fluphenazine.
Suvorexant
Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Talinolol
Fluphenazine may increase the hypotensive activities of Talinolol.
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Fluphenazine.
Tasimelteon
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Tasimelteon.
Tedizolid
The risk or severity of adverse effects can be increased when Tedizolid Phosphate is combined with Fluphenazine.
Tedizolid Phosphate
The risk or severity of adverse effects can be increased when Tedizolid Phosphate is combined with Fluphenazine.
Temazepam
The risk or severity of adverse effects can be increased when Temazepam is combined with Fluphenazine.
Terbinafine
The metabolism of Fluphenazine can be decreased when combined with Terbinafine.
Terbutaline
Fluphenazine may increase the hypotensive activities of Terbutaline.
Terbutaline Sulfate
Fluphenazine may increase the hypotensive activities of Terbutaline.
Tertatolol
Fluphenazine may increase the hypotensive activities of Tertatolol.
Tetrabenazine
The risk or severity of adverse effects can be increased when Tetrabenazine is combined with Fluphenazine.
Tetracaine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Tetracaine.
Tetracaine hydrochloride
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Tetracaine.
Tetrahydrocannabinol
Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Fluphenazine.
Thalidomide
Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Thiamylal
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Thiamylal.
Thiopental
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Thiopental.
Thiopental Sodium
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Thiopental.
Thioridazine
The serum concentration of Thioridazine can be increased when it is combined with Fluphenazine.
Thiothixene
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Thiothixene.
Tiagabine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Tiagabine.
Tiapride
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Tiapride.
Ticlopidine
The metabolism of Fluphenazine can be decreased when combined with Ticlopidine.
Timolol
Fluphenazine may increase the hypotensive activities of Timolol.
Timolol Anhydrous
Fluphenazine may increase the hypotensive activities of Timolol.
Tipranavir
The metabolism of Fluphenazine can be decreased when combined with Tipranavir.
Tizanidine
The serum concentration of Tizanidine can be increased when it is combined with Fluphenazine.
Tolcapone
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Tolcapone.
Topiramate
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Topiramate.
Topotecan
The serum concentration of Topotecan can be increased when it is combined with Fluphenazine.
Tramadol
The risk or severity of adverse effects can be increased when Tramadol is combined with Fluphenazine.
Tranylcypromine
The metabolism of Fluphenazine can be decreased when combined with Tranylcypromine.
Trazodone
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Trazodone.
Triazolam
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Triazolam.
Triazulenone
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Loprazolam.
Trifluoperazine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Trifluoperazine.
Triflupromazine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Triflupromazine.
Trimethoprim
The serum concentration of Fluphenazine can be increased when it is combined with Trimethoprim.
Trimipramine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Trimipramine.
Triprolidine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Triprolidine.
Tromethamine
Tromethamine can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Urethane
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Ethyl carbamate.
Valproate
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Valproic Acid.
Valproic Acid
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Valproic Acid.
Vemurafenib
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Fluphenazine.
Venlafaxine
The metabolism of Fluphenazine can be decreased when combined with Venlafaxine.
Vigabatrin
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Vigabatrin.
Vilazodone
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Vilazodone.
Vincristine
The excretion of Vincristine can be decreased when combined with Fluphenazine.
Vortioxetine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Vortioxetine.
Xylazine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Xylazine.
Zaleplon
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Zaleplon.
Ziconotide
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Ziconotide.
Ziprasidone
The metabolism of Fluphenazine can be decreased when combined with Ziprasidone.
Zolmitriptan
The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Fluphenazine.
Zolpidem
Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Zonisamide
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Zonisamide.
Zopiclone
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Zopiclone.
Zotepine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Zotepine.
Zuclopenthixol
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Zuclopenthixol.
